SEC Form 4 · accession 0001250853-19-000048
EMMAUS LIFE SCIENCES, INC. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Telcon RF Pharmaceutical Inc.
10% Owner
Period of report
Oct 3, 2018
Accepted (ET)
Mar 7, 2019 · 2:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420031
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 3, 2018 | D | 495,000 | $7.60 | D | 3,949,445 | D |
Table II — derivative securities
No Table II lines on this filing.